anayamalik, Author at European Medical Journal - Page 115 of 120

How Long Do Antibiotics Take To Work? 7-Day Change: IDWeek 2024

New research presented at IDWeek 2024 may impact advice patients are given on how long antibiotics take to work following treatment of bloodstream infections.

Home Phototherapy for Psoriasis: Convenient and Effective

A major randomized clinical trial has demonstrated that home-based narrowband UV-B phototherapy is as effective as office-based treatment for patients with plaque or guttate psoriasis.

Avian Flu Detected Early in Wastewater: IDWeek 2024

Avian influenza H5 was detected in municipal wastewater solids during a U.S. cattle outbreak, providing a potential early warning system for future outbreaks.

What’s the Link Between Traumatic Brain Injury and Alzheimer's?

Traumatic brain injury accounts for 30% of all injury-related deaths in the United States, and is a major cause of death and disability in the country.

Personalized Immunotherapy for Resistant Lung Cancer Mutations

A new study from The University of Texas MD Anderson Cancer Center has revealed that a combination of dual immunotherapy and chemotherapy improves outcomes for patients with metastatic NSCLC who harbor specific mutations.

New Research in HSV-2 Recurrence Therapy

HSV-1 and HSV-2 establish latent/reactivation patterns, giving rise to recurrent epithelial lesions, cold sores and genital herpes, in patients. These persistent infections have affected over half of the US adult population yet the pathogenic mechanism is not well understood.

Game-Changing Approach to Glioblastoma Treatment

A promising treatment strategy for glioblastoma has been unveiled in a significant breakthrough that addresses the urgent need for effective therapeutic options.

How is Addison’s Disease Managed?

Addison’s disease is a rare but serious endocrine disorder, which presents unique challenges for healthcare providers.

Understanding Complications of Metabolically Healthy Obesity: CHEST 2024

A nationwide study presented at the CHEST Annual Meeting 2024 revealed rising trends in metabolically healthy obesity (MHO) among elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease

Neighborhood Disadvantages Increase Lung Disease Rates: CHEST 2024

A strong link has been identified between the cumulative impact of neighborhood-level environmental and social factors, known as the “neighborhood exposome,” and the prevalence of asthma and COPD in U.S. adults